Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Am J Physiol Heart Circ Physiol ; 325(1): H149-H162, 2023 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-37204873

RESUMEN

Patients with two congenital heart diseases (CHDs), Ebstein's anomaly (EA) and left ventricular noncompaction (LVNC), suffer higher morbidity than either CHD alone. The genetic etiology and pathogenesis of combined EA/LVNC remain largely unknown. We investigated a familial EA/LVNC case associated with a variant (p.R237C) in the gene encoding Kelch-like protein 26 (KLHL26) by differentiating induced pluripotent stem cells (iPSCs) generated from affected and unaffected family members into cardiomyocytes (iPSC-CMs) and assessing iPSC-CM morphology, function, gene expression, and protein abundance. Compared with unaffected iPSC-CMs, CMs containing the KLHL26 (p.R237C) variant exhibited aberrant morphology including distended endo(sarco)plasmic reticulum (ER/SR) and dysmorphic mitochondria and aberrant function that included decreased contractions per minute, altered calcium transients, and increased proliferation. Pathway enrichment analyses based on RNASeq data indicated that the "structural constituent of muscle" pathway was suppressed, whereas the "ER lumen" pathway was activated. Taken together, these findings suggest that iPSC-CMs containing this KLHL26 (p.R237C) variant develop dysregulated ER/SR, calcium signaling, contractility, and proliferation.NEW & NOTEWORTHY We demonstrate here that iPSCs derived from patients with Ebstein's anomaly and left ventricular noncompaction, when differentiated into cardiomyocytes, display significant structural and functional changes that offer insight into disease pathogenesis, including altered ER/SR and mitochondrial morphology, contractility, and calcium signaling.


Asunto(s)
Anomalía de Ebstein , Células Madre Pluripotentes Inducidas , Humanos , Anomalía de Ebstein/genética , Anomalía de Ebstein/metabolismo , Anomalía de Ebstein/patología , Células Madre Pluripotentes Inducidas/metabolismo , Miocitos Cardíacos/metabolismo , Diferenciación Celular , Señalización del Calcio
2.
J Pak Med Assoc ; 73(2): 328-332, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36800720

RESUMEN

OBJECTIVE: To measure the perception of medical students regarding different methods of active learning, and its association with the year of study. METHODS: The analytical cross-sectional study was conducted at Shalamar Medical and Dental College, Lahore, Pakistan, from May to September 2020, and comprised medical students of either gender from first to final year of studies. Data was collected using an online questionnaire regarding different methods of active learning and e-learning. Perceptions and their association with the year of study were worked out. Data was analysed using SPSS 16. RESULTS: Of the 270 subjects, 155(57.4%) were females and 115(42.5%) were males. Overall, 39(14.4%) students were from the first year of studies, 32(11.9%) second, 47(17.4%) third, 120(44.4%) fourth and 32(11.9%) were from the final year of medical studies. Most students preferred class lectures as the teaching method of choice 240(89%), followed by small group discussions 156(58%). Students showed positive perception of different learning methods except e-learning 78(28.89%). The association between perceptions and the year of study was statistically significant (p< 0.05). CONCLUSIONS: Students apparently enjoyed using different interactive methods, but were apprehensive about online learning.


Asunto(s)
Educación a Distancia , Estudiantes de Medicina , Femenino , Masculino , Humanos , Estudios Transversales , Aprendizaje Basado en Problemas , Academias e Institutos
3.
J Transl Med ; 10: 243, 2012 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-23217165

RESUMEN

BACKGROUND: Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity. Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic option for the cure of AKI. METHODS: MSCs were cultured in four groups SNAP (S-nitroso N-acetyl penicillamine), SNAP + Methylene Blue (MB), MB and a control for in vitro analysis. Cultured MSCs were pre-conditioned with either SNAP (100 µM) or MB (1 µM) or both for 6 hours. Renal ischemia was induced in four groups (as in in vitro study) of rats by clamping the left renal padicle for 45 minutes and then different pre-conditioned stem cells were transplanted. RESULTS: We report that pre-conditioning of MSCs with SNAP enhances their proliferation, survival and engraftment in ischemic kidney. Rat MSCs pre-conditioned with SNAP decreased cell apoptosis and increased proliferation and cytoprotective genes' expression in vitro. Our in vivo data showed enhanced survival and engraftment, proliferation, reduction in fibrosis, significant improvement in renal function and higher expression of pro-survival and pro-angiogenic factors in ischemic renal tissue in SNAP pre-conditioned group of animals. Cytoprotective effects of SNAP pre-conditioning were abrogated by MB, an inhibitor of nitric oxide synthase (NOS) and guanylate cyclase. CONCLUSION: The results of these studies demonstrate that SNAP pre-conditioning might be useful to enhance therapeutic potential of MSCs in attenuating renal ischemia reperfusion injury.


Asunto(s)
Lesión Renal Aguda/terapia , Isquemia/terapia , Riñón/irrigación sanguínea , Riñón/patología , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Lesión Renal Aguda/patología , Animales , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Medios de Cultivo/farmacología , Citoprotección/efectos de los fármacos , Citoprotección/genética , Fibrosis , Regulación de la Expresión Génica/efectos de los fármacos , Isquemia/fisiopatología , Riñón/fisiopatología , Pruebas de Función Renal , Túbulos Renales/efectos de los fármacos , Túbulos Renales/patología , Túbulos Renales/fisiopatología , Masculino , Células Madre Mesenquimatosas/efectos de los fármacos , Células Madre Mesenquimatosas/metabolismo , Neovascularización Fisiológica/efectos de los fármacos , Óxido Nítrico/farmacología , Ratas , Ratas Sprague-Dawley , S-Nitroso-N-Acetilpenicilamina/farmacología
4.
JAMA Cardiol ; 6(7): 841-846, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-33439236

RESUMEN

Importance: Cardiac fibrosis is exceedingly rare in young adults. Identification of genetic variants that cause early-onset cardiomyopathy may inform novel biological pathways. Experimental models and a single case report have linked genetic deficiency of plasminogen activator inhibitor-1 (PAI-1), a downstream target of cardiac transforming growth factor ß, with cardiac fibrosis. Objective: To perform detailed cardiovascular phenotyping and genotyping in young adults from an Amish family with a frameshift variant (c.699_700dupTA) in SERPINE1, the gene that codes for PAI-1. Design, Setting, and Participants: This observational study included participants from 3 related nuclear families from an Amish community in the primary analysis and participants from the extended family in the secondary analysis. Participants were recruited from May 2015 to December 2016, and analysis took place from June 2015 to June 2020. Main Outcomes and Measures: (1) Multimodality cardiovascular imaging (transthoracic echocardiography and cardiac magnetic resonance imaging), (2) whole-exome sequencing, and (3) induced pluripotent stem cell-derived cardiomyocytes. Results: Among 17 participants included in the primary analysis, the mean (interquartile range) age was 23.7 (20.9-29.9) years and 9 individuals (52.9%) were confirmed to be homozygous for the SERPINE1 c.699_700dupTA variant. Late gadolinium enhancement was present in 6 of 9 homozygous participants (67%) with absolute PAI-1 deficiency vs 0 of 8 in the control group (P = .001). Late gadolinium enhancement patterns tended to be dense and linear, usually subepicardial but also midmyocardial and transmural with noncoronary distributions. Targeted whole-exome sequencing analysis identified that homozygosity for c.699_700dupTA SERPINE1 was the only shared pathogenic variant or variant of uncertain significance after examination of cardiomyopathy genes among those with late gadolinium enhancement. Induced pluripotent stem cell-derived cardiomyocytes from participants homozygous for the SERPINE1 c.699_700dupTA variant exhibited susceptibility to cardiomyocyte injury in response to angiotensin II (increased transforming growth factor ß1 secretion and release of lactate dehydrogenase) compared with control induced pluripotent stem cell-derived cardiomyocytes. In a secondary analysis based on echocardiography in 155 individuals across 3 generations in the extended family, no difference in global longitudinal strain was observed in carriers for the SERPINE1 c.699_700dupTA variant compared with wild-type participants, supporting an autosomal recessive inheritance pattern. Conclusions and Relevance: In this study, a highly penetrant, autosomal recessive, cardiac fibrosis phenotype among young adults with homozygous frameshift variant for SERPINE1 was identified, suggesting an optimal range of PAI-1 levels are needed for cardiac homeostasis.


Asunto(s)
Cardiomiopatías/genética , Mutación del Sistema de Lectura/genética , Inhibidor 1 de Activador Plasminogénico/genética , Edad de Inicio , Amish/genética , Cardiomiopatías/diagnóstico por imagen , Cardiomiopatías/patología , Ecocardiografía , Femenino , Fibrosis , Homocigoto , Humanos , Imagen por Resonancia Magnética , Masculino , Secuenciación del Exoma , Adulto Joven
5.
Stem Cell Res ; 18: 33-36, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-28395799

RESUMEN

We have generated a human induced pluripotent stem cell (iPSC) line under feeder-free culture conditions using the urine derived cells (UCs) collected from non-affected control subjects to use as a comparison group for the iPSC lines containing a Plasminogen Activator Inhibitor-1 (PAI-1 homozygous/heterozygous) mutation. The Sendai Virus (SeV) vector encoding pluripotent Yamanaka transcription factors was used at a low multiplicity of infection to reprogram the UCs.


Asunto(s)
Reprogramación Celular , Células Madre Pluripotentes Inducidas/citología , Orina/citología , Secuencia de Bases , Técnicas de Cultivo de Célula/métodos , Línea Celular , Cuerpos Embrioides/metabolismo , Cuerpos Embrioides/patología , Femenino , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Genotipo , Heterocigoto , Homocigoto , Humanos , Células Madre Pluripotentes Inducidas/metabolismo , Cariotipo , Microscopía Fluorescente , Inhibidor 1 de Activador Plasminogénico/genética , Inhibidor 1 de Activador Plasminogénico/metabolismo , Virus Sendai/genética , Análisis de Secuencia de ADN , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
6.
Stem Cell Res ; 18: 41-44, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-28395801

RESUMEN

We have generated a human induced pluripotent stem cell (iPSC) line under feeder-free culture conditions using the urine derived cells (UCs) collected from subjects heterozygous for a novel Plasminogen Activator Inhibitor-1 (PAI-1) mutation. The Sendai Virus (SeV) vector encoding pluripotent Yamanaka transcription factors was used at a low multiplicity of infection to reprogram the PAI-1 UCs.


Asunto(s)
Reprogramación Celular , Células Madre Pluripotentes Inducidas/citología , Inhibidor 1 de Activador Plasminogénico/genética , Orina/citología , Técnicas de Cultivo de Célula , Diferenciación Celular , Línea Celular , Cuerpos Embrioides/metabolismo , Cuerpos Embrioides/patología , Femenino , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Heterocigoto , Humanos , Células Madre Pluripotentes Inducidas/metabolismo , Cariotipo , Microscopía Fluorescente , Polimorfismo Genético , Virus Sendai/genética
7.
Stem Cell Res ; 17(3): 657-660, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27934602

RESUMEN

We have generated a human induced pluripotent stem cell (iPSC) line under feeder-free culture conditions using the urine derived cells (UCs) collected from subject with a novel homozygous Plasminogen Activator Inhibitor-1 (PAI-1 null) mutation. The Sendai virus (SeV) vector encoding pluripotent Yamanaka transcription factors was used at a low multiplicity of infection to reprogram the PAI-1 UCs.


Asunto(s)
Células Madre Pluripotentes Inducidas/citología , Inhibidor 1 de Activador Plasminogénico/genética , Secuencia de Bases , Diferenciación Celular , Línea Celular , Reprogramación Celular , Análisis Mutacional de ADN , Cuerpos Embrioides/citología , Cuerpos Embrioides/metabolismo , Femenino , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Homocigoto , Humanos , Células Madre Pluripotentes Inducidas/metabolismo , Cariotipo , Microscopía Fluorescente , Mutagénesis Insercional , Virus Sendai/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Orina/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA